Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

INTACT GENOMICS INC ig ccdB Resist™ Electrocompetent E. coli Cells 12x50μl

Supplier:  INTACT GENOMICS INC 126924

Encompass_Preferred

Intact Genomics (ig) ccdB Resist™ ElectroCompetent E. coli cells are suitable for high efficiency transformation in a wide variety of applications such as cloning and sub-cloning. ccdB Resist™ cells are capable of propagation of plasmids containing the ccdB gene. Intact Genomics ccdB Resist™ ElectroCompetent Cells provide superb transformation efficiency, higher than any competitor’s similar product, allowing for increased opportunity for experimental success.ig ccdB Resist™ Electrocompetent Cells have the following features: ccdB Resist™ allows for cloning of methylated genomic sequences Stabilizes retroviral and direct repeat sequences including HIV High transformation efficiency allows aids in cloning rare sequences May be used for plasmids > 20 kb endA1 mutation increases plasmid yield significantlyProduct Include and Storage:ig ccdB Resist™ ElectroCompetent Cells: -80 ºCpUC19 control DNA: -20 ºCRecovery medium: 4 ºC

Catalog No. 50-000-82892


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.